{
    "clinical_study": {
        "@rank": "85612", 
        "arm_group": [
            {
                "arm_group_label": "Standard care", 
                "arm_group_type": "No Intervention", 
                "description": "This arm represents the current standard care in patients with thyroid cancer undergoing radioiodine."
            }, 
            {
                "arm_group_label": "Candy plus thymus honey mouthwash 12", 
                "arm_group_type": "Experimental", 
                "description": "This arm will consist 30 patients and will be the one of the intervention groups where each patient will be instructed to suck 1 or 2 lemon candies every 2-3 h in the daytime plus 4 thymus honey mouthwashes in between (at least one hour after the candy sucking) starting 12 hours after the ingestion of 131I therapy and for a duration of no more than 4 days."
            }, 
            {
                "arm_group_label": "Candy plus thymus honey mouthwash 24", 
                "arm_group_type": "Experimental", 
                "description": "This arm will consist 30 patients and will be the one of the intervention groups where each patient will be instructed to suck 1 or 2 lemon candies every 2-3 h in the daytime plus 4 thymus honey mouthwashes in between (at least one hour after the candy sucking) starting 24 hours after the ingestion of 131I therapy and for a duration of no more than 4 days."
            }, 
            {
                "arm_group_label": "Candy plus thymus honey mouthwash 1", 
                "arm_group_type": "Experimental", 
                "description": "This arm will consist 30 patients and will be the one of the intervention groups where each patient will be instructed to suck 1 or 2 lemon candies every 2-3 h in the daytime plus 4 thymus honey mouthwashes in between (at least one hour after the candy sucking) starting immediate after the ingestion of 131I therapy (about 1 hour) and for a duration of no more than 4 days"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether the use of honey mouthwashes in the\n      prevention of salivary side effects of 131I (radioiodine) therapy."
        }, 
        "brief_title": "The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Thyroid Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Thyroid Neoplasms", 
                "Thyroid Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  >18 years old\n\n          -  They had a histological diagnosis of papillary, follicular, medullary or  anaplastic\n             thyroid cancer\n\n          -  They had undergone total thyroidectomy\n\n          -  They were able to provide consent\n\n        Exclusion Criteria:\n\n          -  patients who had distant metastases,\n\n          -  a history of salivary-gland disorders,\n\n          -  collagen tissue disease\n\n          -  diabetes mellitus,\n\n          -  previous radioiodine therapy or external radiation to the head or neck\n\n          -  allergy to the honey"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01833650", 
            "org_study_id": "AC-HCS-89"
        }, 
        "intervention": {
            "arm_group_label": [
                "Candy plus thymus honey mouthwash 12", 
                "Candy plus thymus honey mouthwash 24", 
                "Candy plus thymus honey mouthwash 1"
            ], 
            "intervention_name": "thymus honey mouthwash", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "thyroid cancer", 
            "radioiodine treatment", 
            "xerostomia", 
            "sialadenitis"
        ], 
        "lastchanged_date": "April 13, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Nicosia", 
                    "country": "Cyprus", 
                    "zip": "2006"
                }, 
                "name": "Bank of Cyprus Oncology"
            }, 
            "investigator": {
                "last_name": "Andri Christou, MSc", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Cyprus"
        }, 
        "number_of_arms": "4", 
        "official_title": "A Randomized Controlled Trial of the Effectiveness of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer", 
        "other_outcome": {
            "measure": "Salivary Quantity (Quantitative Salivary Scintigraphy)", 
            "safety_issue": "No", 
            "time_frame": "Change from Baseline quantity of saliva at 6 and 24 months"
        }, 
        "overall_contact": {
            "email": "andreas.charalambous@cut.ac.cy", 
            "last_name": "Andreas Charalambous, PhD", 
            "phone": "+35725002011"
        }, 
        "overall_contact_backup": {
            "email": "savvas.frangos@bococ.org.cy", 
            "last_name": "Savvas Frangos, MD", 
            "phone": "+35722841300"
        }, 
        "overall_official": {
            "affiliation": "Cyprus University of Technology", 
            "last_name": "Andreas Charalambous, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Cyprus: Bank of Cyprus Oncology Center Research Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Grade of sialadenitis", 
            "safety_issue": "No", 
            "time_frame": "Change from Baseline grade of sialadenitis at 6 and 24 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01833650"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Cyprus University of Technology", 
            "investigator_full_name": "Dr. Andreas Charalambous", 
            "investigator_title": "Lecturer of Oncology and Palliative Care", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Grade of Xerostomia", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline grade of xerostomia at 6 and 24 months"
            }, 
            {
                "measure": "Level of Health related quality of life", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline level of health related quality of life at 6 and 24 months"
            }
        ], 
        "source": "Cyprus University of Technology", 
        "sponsors": {
            "collaborator": {
                "agency": "Bank of Cyprus Oncology Centre", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Cyprus University of Technology", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}